Literature DB >> 12480811

Brugada syndrome: a decade of progress.

C Antzelevitch1, P Brugada, J Brugada, R Brugada, W Shimizu, I Gussak, A R Perez Riera.   

Abstract

The Brugada syndrome has gained wide recognition throughout the world and today is believed to be responsible for 4% to 12% of all sudden deaths and approximately 20% of deaths in patients with structurally normal hearts. The incidence of the disease is on the order of 5 per 10 000 inhabitants and, apart from accidents, is the leading cause of death of men under the age of 50 in regions of the world where the inherited syndrome is endemic. This minireview briefly summarizes the progress made over the past decade in our understanding of the clinical, genetic, cellular, ionic, and molecular aspects of this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480811     DOI: 10.1161/01.res.0000046046.53721.90

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  52 in total

1.  Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome.

Authors:  Kevin Vernooy; Serge Sicouri; Robert Dumaine; Kui Hong; Antonio Oliva; Elena Burashnikov; Carl Timmermans; Tammo Delhaas; Harry J G M Crijns; Charles Antzelevitch; Luz-Maria Rodriguez; Ramon Brugada
Journal:  Heart Rhythm       Date:  2006-07-07       Impact factor: 6.343

2.  Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.

Authors:  Christian Wolpert; Constanze Echternach; Christian Veltmann; Charles Antzelevitch; George P Thomas; Susanne Spehl; Florian Streitner; Juergen Kuschyk; Rainer Schimpf; Karl K Haase; Martin Borggrefe
Journal:  Heart Rhythm       Date:  2005-03       Impact factor: 6.343

Review 3.  Brugada syndrome.

Authors:  Johnson Francis; Charles Antzelevitch
Journal:  Int J Cardiol       Date:  2005-05-25       Impact factor: 4.164

Review 4.  The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis.

Authors:  Charles Antzelevitch; Luiz Belardinelli
Journal:  J Cardiovasc Electrophysiol       Date:  2006-05

5.  Computer simulation of wild-type and mutant human cardiac Na+ current.

Authors:  Stefania Vecchietti; Ilaria Rivolta; Stefano Severi; Carlo Napolitano; Silvia G Priori; Silvio Cavalcanti
Journal:  Med Biol Eng Comput       Date:  2006-03       Impact factor: 2.602

Review 6.  Modulation of transmural repolarization.

Authors:  Charles Antzelevitch
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 7.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

Review 8.  Cardiac repolarization. The long and short of it.

Authors:  Charles Antzelevitch
Journal:  Europace       Date:  2005-09       Impact factor: 5.214

9.  Current Management of Syncope: Treatment Alternatives.

Authors:  Carlos A. Morillo; Adrián Baranchuk
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

Review 10.  Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease.

Authors:  Ijaz A Khan; Chandra K Nair
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.